Aspirin is not benign.
Self- prescribing or taking it ongoing regularly, aka like a medication-needs to be weighed up against lifetime actual risks which exceed for instance a perceived lowering of overall risk for developing cancer.
Aspirin is dangerous, should not be taken by anyone who is pregnant !
We do not advise at all to give it to children under12years of age, really at all , unless prescribed by a very qualified health professional.
Due to the significant risk of Reye syndrome .
https://en.wikipedia.org/wiki/Reye_syndromeParacetamol, although yes ironically it might struggle to gain approval in modern times now- is judged safer, without risk of harm to the kidneys
Posting only because you quote aspirin as example.
Re safety and potential adverse effects warnings glossing over with aspirin as comparison.
Good example : direct comparison-
Aspirin should not be , and cannot be given to renal disease patients.
Harmful.
I hope the steady improvement, safer drug overall with simpler dosing , profile of DXB200 - leads to trial overall success and accelerated approvals.
A drug like Dimerix has very much has a place in global health for slowing and management of kidney disease.
Nice interview with Nina in recent days , online with Marcus Today - significant to remember always that patients who have completed phase 3 trial, large number continue to take DXB200 now, whether they were in the treatment arm or placebo group once they were unblinded
Really heartening that seen as worthwhile and making a difference to manage patients significant renal condition, and highly positive in my eyes.
(20min delay)